Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
![A single combination pill can improve blood pressure control, reduce polypharmacy](/~/media/slack-news/stock-images/pulmonology/p/person-holding-a-pill_adobe.jpg?w=400)
A single combination pill can improve blood pressure control, reduce polypharmacy
A polypill containing multiple blood pressure-lowering drugs may be an effective solution to addressing both uncontrolled hypertension and polypharmacy causing non-adherence to antihypertensive medications, speakers reported.
Timing of blood pressure medication may not matter for reducing CV event risk
![Timing of blood pressure medication may not matter for reducing CV event risk](/~/media/slack-news/cardiology/mugs/t/turgeon_ricky_2023_web.jpg?w=80)
The timing of when a patient takes their blood pressure medication does not appear to matter for reducing CV event risk, according to two trials and a meta-analysis presented at the European Society of Cardiology Congress.
Nondeceptive placebos effective, easy to use for patients with COVID-19-related stress
![Nondeceptive placebos effective, easy to use for patients with COVID-19-related stress](/~/media/slack-news/stock-images/psychiatry/w/woman.jpg?w=400)
Placebos administered without deception, or nondeceptive placebos, may offer an alternative and effective way to help people manage prolonged stress, according to a study published in Applied Psychology: Health and Well-Being.
Log in or Sign up for Free to view tailored content for your specialty!
New eligibility for semaglutide would cost Medicare billions in spending
![New eligibility for semaglutide would cost Medicare billions in spending](/~/media/slack-news/fm_im/misc/infographics/2024/08-august/pc0824chaitoff_graphic_01_web.jpg?w=400)
High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.
FDA greenlights updated COVID-19 vaccines for rollout
![FDA greenlights updated COVID-19 vaccines for rollout](/~/media/slack-news/stock-images/rheumatology/f/fda_news_alert_healio_23007093.jpg?w=400)
The FDA on Thursday announced that it has greenlit the updated COVID-19 vaccines manufactured by Moderna and Pfizer-BioNTech, which the companies said should be available within days.
IDSA updates guidance on resistant gram-negative infections
![IDSA updates guidance on resistant gram-negative infections](/~/media/slack-news/infectious-disease/misc/other/hospital_beds_adobe.jpg?w=400)
The Infectious Diseases Society of America has updated its guidance on the treatment of antimicrobial-resistant gram-negative infections and said it aims to update the guidelines annually to keep up with evolving resistance and new research.
Lowest price for top generic drugs in US varies among six discount programs
![Lowest price for top generic drugs in US varies among six discount programs](/~/media/slack-news/endocrinology/mugs/m/masuda_camlyn_2024_web.jpg?w=80)
A 90-day supply of most of the top generic drugs in the U.S. can be purchased from a discount program for $15 or less, but none of the programs consistently offer the lowest prices for generic drugs, according to two presenters.
Tom McCourt on discovery, trust, friendship and courage
![Tom McCourt on discovery, trust, friendship and courage](/~/media/images/collections/gastroenterology/resources/podcasts/guttalk_mug.jpeg?w=80)
In this podcast episode, Tom McCourt, chief executive officer of Ironwood Pharmaceuticals, discusses the evolving relationship between physicians and pharma, breakthroughs in GI drugs and more.
Many prescriptions for acute sinusitis do not follow guidelines
![Many prescriptions for acute sinusitis do not follow guidelines](/~/media/slack-news/infectious-disease/misc/other/pharmacist-dispenses-drugs_71281879.jpeg?w=400)
More than half of antibiotic prescriptions for acute sinusitis follow prescribing guidelines, but nearly one-third do not, and most prescriptions are given for too long a duration, according to a study.
Medicare announces price cuts for 10 drugs in first round of drug price negotiations
![Medicare announces price cuts for 10 drugs in first round of drug price negotiations](/~/media/slack-news/endocrinology/misc/infographics/2024/08_august/et0824medicaredrugprices_mm_ig.jpg?w=400)
The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.
-
Headline News
Mental health of health workers remains a major concern following pandemic
September 05, 20244 min read -
Headline News
How PCPs can use social drivers of health 'to affect positive change' in their communities
September 04, 20246 min read -
Headline News
QWINT: Once-weekly basal insulin noninferior to daily insulins in type 2 diabetes
September 05, 20243 min read
-
Headline News
Mental health of health workers remains a major concern following pandemic
September 05, 20244 min read -
Headline News
How PCPs can use social drivers of health 'to affect positive change' in their communities
September 04, 20246 min read -
Headline News
QWINT: Once-weekly basal insulin noninferior to daily insulins in type 2 diabetes
September 05, 20243 min read